ATE101590T1 - 5,6,7,8-tetrahydro-1-naphthalenolderivate, verfahren zu ihrer herstellung und ihre verwendung als antioxidationsmittel in kosmetischen und pharmazeutischen zusammensetzungen. - Google Patents

5,6,7,8-tetrahydro-1-naphthalenolderivate, verfahren zu ihrer herstellung und ihre verwendung als antioxidationsmittel in kosmetischen und pharmazeutischen zusammensetzungen.

Info

Publication number
ATE101590T1
ATE101590T1 AT90401641T AT90401641T ATE101590T1 AT E101590 T1 ATE101590 T1 AT E101590T1 AT 90401641 T AT90401641 T AT 90401641T AT 90401641 T AT90401641 T AT 90401641T AT E101590 T1 ATE101590 T1 AT E101590T1
Authority
AT
Austria
Prior art keywords
radical
tetrahydro
antioxidants
alkyl radical
pharmaceutical compositions
Prior art date
Application number
AT90401641T
Other languages
English (en)
Inventor
Jean Maignan
Gerard Malle
Andre Deflandre
Gerard Lang
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE101590T1 publication Critical patent/ATE101590T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/10—Quinones the quinoid structure being part of a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C07C65/26—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic containing rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
AT90401641T 1989-06-13 1990-06-13 5,6,7,8-tetrahydro-1-naphthalenolderivate, verfahren zu ihrer herstellung und ihre verwendung als antioxidationsmittel in kosmetischen und pharmazeutischen zusammensetzungen. ATE101590T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8907805A FR2648131B1 (fr) 1989-06-13 1989-06-13 Nouveaux derives de tetrahydro -5,6,7,8 naphtalenol-1, leur procede de preparation et leur utilisation en tant qu'agents antioxydants dans des compositions cosmetiques et pharmaceutiques les contenant
EP90401641A EP0404640B1 (de) 1989-06-13 1990-06-13 5,6,7,8-Tetrahydro-1-naphthalenolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antioxidationsmittel in kosmetischen und pharmazeutischen Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE101590T1 true ATE101590T1 (de) 1994-03-15

Family

ID=9382658

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90401641T ATE101590T1 (de) 1989-06-13 1990-06-13 5,6,7,8-tetrahydro-1-naphthalenolderivate, verfahren zu ihrer herstellung und ihre verwendung als antioxidationsmittel in kosmetischen und pharmazeutischen zusammensetzungen.

Country Status (9)

Country Link
US (2) US5043482A (de)
EP (1) EP0404640B1 (de)
JP (1) JPH0363240A (de)
AT (1) ATE101590T1 (de)
AU (1) AU627036B2 (de)
CA (1) CA2018959A1 (de)
DE (1) DE69006647T2 (de)
ES (1) ES2062442T3 (de)
FR (1) FR2648131B1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4033568A1 (de) * 1990-10-22 1992-04-23 Henkel Kgaa Bicyclische verbindungen mit antiseborrhoischer wirkung
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19850474A1 (de) 1998-11-02 2000-05-04 Varta Geraetebatterie Gmbh Verfahren zur Herstellung einer positiven Elektrode für ein alkalisches Primärelement
CA2487945A1 (fr) 2002-06-11 2003-12-18 L'oreal Utilisation d'un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) comme agent protecteur des melanocytes du follicule pileux et applications
FR2840531B1 (fr) * 2002-06-11 2004-10-29 Oreal Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426358A (en) * 1965-11-19 1969-02-04 Hooker Chemical Corp Alkylation of phenols
US3830854A (en) * 1970-01-08 1974-08-20 Allied Chem Substituted 5,8-dimethyl-5,6,7,8-tetrahydro-1-naphthols
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
FR2246528A1 (en) * 1973-10-04 1975-05-02 Roussel Uclaf Di-substd hydroquinone and esterified derivs as antioxidants - esp for use in cosmetic prepns to reduce skin aging
DE3434944A1 (de) * 1984-09-22 1986-04-03 Basf Ag, 6700 Ludwigshafen L-substituierte tetralinderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
CA2018959A1 (fr) 1990-12-13
EP0404640A1 (de) 1990-12-27
EP0404640B1 (de) 1994-02-16
US5043482A (en) 1991-08-27
FR2648131A1 (fr) 1990-12-14
ES2062442T3 (es) 1994-12-16
AU627036B2 (en) 1992-08-13
AU5695390A (en) 1990-12-20
DE69006647T2 (de) 1994-05-26
FR2648131B1 (fr) 1991-10-18
DE69006647D1 (de) 1994-03-24
JPH0363240A (ja) 1991-03-19
US5158977A (en) 1992-10-27

Similar Documents

Publication Publication Date Title
ATE40819T1 (de) 4-vinylbenzoesaeure-derivate, ihre herstellung und verwendung als arzneimittel und ligande.
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
ATE147071T1 (de) 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung
ATE73790T1 (de) Amino 5,6,7,8tetrahydronaphtho(2,3b>furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE164578T1 (de) Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten
ZA948078B (en) Inclusion complex.
ES2147616T3 (es) Derivados de piperidina con actividad antagonista del paf.
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
NO894410L (no) Fremgangsmaate for fremstilling av 3,5-dimetyl-4-metoksypyridinderivater samt nye mellomprodukter for dette formaal.
ATE101590T1 (de) 5,6,7,8-tetrahydro-1-naphthalenolderivate, verfahren zu ihrer herstellung und ihre verwendung als antioxidationsmittel in kosmetischen und pharmazeutischen zusammensetzungen.
DE69510338D1 (de) Azirdin-derivate, deren herstellung und verwendung
IT1196423B (it) Benzotiazolin-composti
PT96849A (pt) Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s)
FI954138A0 (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
AU551938B2 (en) 6-chloro 4-phenyl quinazoline derivatives
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
SE8206548D0 (sv) Bensylidenderivat
DE3781383D1 (de) 2,2-dimethylcyclopropancarbonsaeurederivate, die eine gesaettigte halogenierte kette an c-3 tragen, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als pestizide und sie enthaltende zusammensetzungen.
DE68902627D1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
EP0802179A4 (de) Derivate substituierter amidinonaphthylester
IL99369A0 (en) Pharmaceutical compositions containing substituted 2-cyclohexene derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties